Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global acute myeloid leukemia therapeutics market size reached US$ 1,073.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,199.1 Million by 2028, exhibiting a growth rate (CAGR) of 12.7% during 2022-2028.
Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It primarily impacts the bone marrow and white blood cells (WBCs) and is characterized by the discoloration of skin, breathlessness, fatigue, high body temperatures, weight loss, bleeding gums and nosebleeds. Some of the commonly used AML therapies include chemo-, immuno-, targeted- and hormonal therapies and surgical procedures. These therapeutics are usually combined with stem cell transplants to increase the efficacy, minimize complications and strengthen the immune system of the body.
The increasing prevalence of leukemia across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such disorders, is also driving the market growth. AML is primarily caused by genetic mutations in the body that impacts the levels of blood cell production. In line with this, the widespread adoption of combination and targeted therapies and increasing awareness regarding the available alternatives for cancer treatment are also favoring the market growth. Additionally, the advent of improved immunotoxins, alkylating agents, monoclonal antibodies and multidrug-resistant modulators is another major growth-inducing factor. These therapeutics offer prolonged results, higher efficacy, early and accurate identification of leukemia cells and reduced chances of cancer relapse. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with significant improvements in the existing healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global acute myeloid leukemia therapeutics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on treatment type, drug type and route of administration.
Breakup by Treatment Type:
Cytarabine
Anthracycline Drugs
Alkylating Agents
Anti-Metabolites
Tyrosine Kinase Inhibitors
Others
Breakup by Drug Type:
Small Molecule Drugs
Biopharmaceuticals
Breakup by Route of Administration:
Oral
Injectables
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Celgene, Roche Holding AG, Gilead Sciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global acute myeloid leukemia therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global acute myeloid leukemia therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global acute myeloid leukemia therapeutics market and who are the key players?
What is the degree of competition in the industry?
Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It primarily impacts the bone marrow and white blood cells (WBCs) and is characterized by the discoloration of skin, breathlessness, fatigue, high body temperatures, weight loss, bleeding gums and nosebleeds. Some of the commonly used AML therapies include chemo-, immuno-, targeted- and hormonal therapies and surgical procedures. These therapeutics are usually combined with stem cell transplants to increase the efficacy, minimize complications and strengthen the immune system of the body.
The increasing prevalence of leukemia across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such disorders, is also driving the market growth. AML is primarily caused by genetic mutations in the body that impacts the levels of blood cell production. In line with this, the widespread adoption of combination and targeted therapies and increasing awareness regarding the available alternatives for cancer treatment are also favoring the market growth. Additionally, the advent of improved immunotoxins, alkylating agents, monoclonal antibodies and multidrug-resistant modulators is another major growth-inducing factor. These therapeutics offer prolonged results, higher efficacy, early and accurate identification of leukemia cells and reduced chances of cancer relapse. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with significant improvements in the existing healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global acute myeloid leukemia therapeutics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on treatment type, drug type and route of administration.
Breakup by Treatment Type:
Cytarabine
Anthracycline Drugs
Alkylating Agents
Anti-Metabolites
Tyrosine Kinase Inhibitors
Others
Breakup by Drug Type:
Small Molecule Drugs
Biopharmaceuticals
Breakup by Route of Administration:
Oral
Injectables
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Celgene, Roche Holding AG, Gilead Sciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global acute myeloid leukemia therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global acute myeloid leukemia therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global acute myeloid leukemia therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ACUTE MYELOID LEUKEMIA THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TREATMENT TYPE
6.1 Cytarabine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anthracycline Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alkylating Agents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Anti-Metabolites
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tyrosine Kinase Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY DRUG TYPE
7.1 Small Molecule Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biopharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Celgene
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Roche Holding AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Gilead Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ACUTE MYELOID LEUKEMIA THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TREATMENT TYPE
6.1 Cytarabine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anthracycline Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alkylating Agents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Anti-Metabolites
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tyrosine Kinase Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY DRUG TYPE
7.1 Small Molecule Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biopharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Celgene
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Roche Holding AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Gilead Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Acute Myeloid Leukemia Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Acute Myeloid Leukemia Therapeutics Market: Competitive Structure
Table 7: Global: Acute Myeloid Leukemia Therapeutics Market: Key Players
Table 1: Global: Acute Myeloid Leukemia Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Acute Myeloid Leukemia Therapeutics Market: Competitive Structure
Table 7: Global: Acute Myeloid Leukemia Therapeutics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Acute Myeloid Leukemia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Treatment Type (in %), 2022
Figure 5: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Acute Myeloid Leukemia Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Acute Myeloid Leukemia Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2022
Figure 77: Global: Acute Myeloid Leukemia Therapeutics Industry: SWOT Analysis
Figure 78: Global: Acute Myeloid Leukemia Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Acute Myeloid Leukemia Therapeutics Industry: Porter's Five Forces Analysis
Figure 1: Global: Acute Myeloid Leukemia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Treatment Type (in %), 2022
Figure 5: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Acute Myeloid Leukemia Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Acute Myeloid Leukemia Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2022
Figure 77: Global: Acute Myeloid Leukemia Therapeutics Industry: SWOT Analysis
Figure 78: Global: Acute Myeloid Leukemia Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Acute Myeloid Leukemia Therapeutics Industry: Porter's Five Forces Analysis
